Clinical Trials Logo

Recurrent Small Cell Lung Cancer clinical trials

View clinical trials related to Recurrent Small Cell Lung Cancer.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03732846 Recruiting - Clinical trials for Recurrent Small Cell Lung Cancer

Anlotinib in Treatment of Recurrent Small Cell Lung Cancer

Start date: November 1, 2018
Phase: Phase 2
Study type: Interventional

Exploring the efficacy and safety of Anlotinib in patients with relapsed small cell lung cancer

NCT ID: NCT00168922 Recruiting - Clinical trials for Recurrent Small Cell Lung Cancer

Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

Start date: February 2001
Phase: Phase 2
Study type: Interventional

Determination of response rate Assessment of toxicity and determination of "time to progression"